Universal Biosensors Inc Quick Ratio (UBI) starting from the third quarter 2024 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Universal Biosensors Inc   (UBI)

Universal Biosensors Inc 's Quick Ratio

UBI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2024, Quick Ratio deteriorated to 1.98 below Universal Biosensors Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 47 other companies have achieved higher Quick Ratio than Universal Biosensors Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 441 to 714.

Explain Quick Ratio?
How much Cash & cash equivalents UBI´s has?
What are UBI´s Current Liabilities?




UBI Quick Ratio (Sep 30 2024)
Q2
(Jun 30 2024)
Q1
(Jun 30 2023)
Q4
(Mar 31 2023)
Q3
(Dec 31 2022)
Q2
Y / Y Current Liabilities Change -65.08 % -63.09 % -28.54 % 15.07 % 48.5 %
Y / Y Cash & cash equivalent Change -51.56 % -35.77 % -50.08 % 73.71 % 58.96 %
Quick Ratio MRQ 1.98 2.47 1.46 1.14 1.43
UBI's Total Ranking # 714 # 441 # 0 # 0 # 0
Seq. Current Liabilities Change -4.19 % -39.5 % -39.72 % -0.06 % 1.28 %
Seq. Cash & cash equivalent Change -23.09 % 2.37 % -22.58 % -20.53 % 1.97 %



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 48
Healthcare Sector # 360
Overall Market # 714


Quick Ratio Statistics
High Average Low
3.7 2.27 0.89
(Jun 30 2024)   (Dec 31 2018)




Financial Statements
Universal Biosensors Inc 's Current Liabilities $ 4 Millions Visit UBI's Balance sheet
Universal Biosensors Inc 's Cash & cash equivalent $ 9 Millions Visit UBI's Balance sheet
Source of UBI's Sales Visit UBI's Sales by Geography


Cumulative Universal Biosensors Inc 's Quick Ratio

UBI's Quick Ratio for the trailling 12 Months

UBI Quick Ratio

(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth -37.4 % -12.04 % 21.61 % 43.19 % 52.74 %
Y / Y Cash & cash equivalent TTM Growth -31.24 % -7.88 % 14.97 % 59.28 % 24.4 %
Quick Ratio TTM 1.56 1.46 1.35 1.49 1.42
Total Ranking TTM # 3103 # 64 # 0 # 0 # 0
Seq. Current Liabilities TTM Growth -21.94 % -17.36 % -6.28 % 3.54 % 9.68 %
Seq. Cash & cash equivalent TTM Growth -16.96 % -10.35 % -15.4 % 9.19 % 11.24 %


On the trailing twelve months basis Current Liabilities decreased faster than Universal Biosensors Inc 's average Cash & cash equivalent, this led to increase in in Universal Biosensors Inc 's Quick Ratio to 1.56, Quick Ratio remained below UBI average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 185 other companies have achieved higher Quick Ratio than Universal Biosensors Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 64 to 3103.

Explain Quick Ratio?
How much Cash & cash equivalents UBI´s has?
What are UBI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 186
Healthcare Sector # 846
Within the Market # 3103


trailing twelve months Quick Ratio Statistics
High Average Low
4.16 2.3 1.66
(Dec 31 2020)   (Mar 31 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2024, within Medical Equipment & Supplies Industry Quick RatioSep 30 2024 MRQ Cash & cash equivalentSep 30 2024 MRQ Current Liabilities
Fractyl Health Inc   5.39 $ 84.664  Millions$ 15.717  Millions
Axonics Inc   5.36 $ 345.225  Millions$ 64.419  Millions
Tactile Systems Technology Inc   5.11 $ 82.146  Millions$ 16.088  Millions
Nakamoto Inc   5.03 $ 3.654  Millions$ 0.726  Millions
Hyperfine Inc   4.60 $ 45.765  Millions$ 9.959  Millions
Nutriband Inc   4.57 $ 5.698  Millions$ 1.248  Millions
Brainsway Ltd   4.52 $ 69.345  Millions$ 15.346  Millions
Sensus Healthcare Inc   4.33 $ 22.558  Millions$ 5.210  Millions
Beyond Air Inc   4.31 $ 28.447  Millions$ 6.599  Millions
Orchestra Biomed Holdings Inc   4.23 $ 66.926  Millions$ 15.823  Millions
Lemaitre Vascular Inc   4.22 $ 123.889  Millions$ 29.343  Millions
Outset Medical Inc   4.14 $ 175.633  Millions$ 42.430  Millions
Autonomix Medical Inc   4.10 $ 5.155  Millions$ 1.257  Millions
Valion Bio Inc   3.91 $ 2.189  Millions$ 0.560  Millions
Avita Medical Inc   3.89 $ 66.666  Millions$ 17.141  Millions
Neuropace Inc   3.84 $ 56.830  Millions$ 14.781  Millions
Procept Biorobotics Corporation  3.67 $ 196.762  Millions$ 53.646  Millions
Glaukos Corp  3.66 $ 262.473  Millions$ 71.684  Millions
Adagio Medical Holdings inc   3.57 $ 28.260  Millions$ 7.919  Millions
Anika Therapeutics Inc   3.56 $ 90.725  Millions$ 25.493  Millions
Staar Surgical Co  3.56 $ 235.958  Millions$ 66.341  Millions
Pulmonx Corporation  3.46 $ 63.312  Millions$ 18.300  Millions
Lyra Therapeutics Inc   3.45 $ 51.626  Millions$ 14.954  Millions
Femasys Inc   3.38 $ 7.611  Millions$ 2.250  Millions
Microbot Medical Inc   3.36 $ 4.386  Millions$ 1.306  Millions
Logicmark Inc  3.23 $ 5.586  Millions$ 1.731  Millions
Vivani Medical Inc   3.13 $ 19.646  Millions$ 6.270  Millions
Heartbeam Inc   3.11 $ 5.768  Millions$ 1.856  Millions
Icad Inc  3.00 $ 18.793  Millions$ 6.272  Millions
Aethlon Medical Inc   2.94 $ 6.859  Millions$ 2.332  Millions

Date modified: 2026-09-26T06:59:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.